The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up

Tue, 23rd Oct 2012 09:23

Aggreko: UBS cuts target from 2,750p to 2,550p, buy rating kept.ARM Holdings: Investec keeps buy rating and 800p target.Avacta: Panmure Gordon keeps buy rating and 1.75p target.AZ Electronic: Canaccord Genuity ups target from 360p to 376p, buy rating kept.Babcock: JPMorgan Cazenove ups target from 990p to 1,050p, overweight rating kept.Barclays: Exane BNP Paribas ups target from 330p to 340p, outperform rating kept; HSBC lifts target from 180p to 260p, neutral rating kept.BBA Aviation: Westhouse Securities downgrades to neutral.BP: Jefferies keeps hold rating and 450p target.BP Marsh & Partners: Panmure Gordon ups target from 125p to 130p, buy rating kept.British American Tobacco: Credit Suisse ups target from 3,400p to 3,430p, outperform rating kept.Bullabulling Gold: Westhouse Securities initiates with buy rating and 21p target..Burberry: Deutsche Bank keeps hold rating and 1,275p target.CRH: HSBC downgrades to neutral, target cut from 16p to 15p.Direct Line: Nomura initiates with reduce rating and 174p target.e-Therapeutics: Panmure Gordon keeps buy rating and 73p target.Experian: Jefferies keeps buy rating and 1,060p target; Seymour Pierce keeps reduce rating and 1,000p target.Genel Energy: HSBC downgrades to neutral, target upped from 816p to 830p.Hammerson: Jefferies raises target from 501p to 503p, hold rating kept.Inchcape: Panmure Gordon keeps hold rating and 430p target.Johnson Matthey: UBS cuts target from 2,378p to 2,300p, neutral rating kept.Laird: Investec keeps hold rating and 225p target.Mulberry: Barclays Capital cuts target from 1,600p to 1,250p, equal weight rating kept; Panmure Gordon slashes target from 2,000p to 1,100p, buy rating kept.N Brown: UBS ups target from 285p to 340p, buy rating kept.Premier Foods: Panmure Gordon keeps hold rating and 90p target; Investec puts buy rating and 100p target under review.Redrow: UBS downgrades to neutral, target lifted from 160p to 170p.SDL: Goldman Sachs cuts target from 915p to 820p, buy rating kept.Unilever: Oriel Securities downgrades to hold, target raised from 2,200p to 2,320p.Whitbread: Investec maintains sell rating and 1,650p target; Nomura maintains buy rating and 2,650p target; Panmure Gordon keeps hold rating and 1,994p target; Investec keeps sell rating and 1,650p target.BC
More News
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
21 May 2015 08:23

e-Therapeutics Says First Patient Enrolled In Phase Ib ETS2101 Trial

Read more
31 Mar 2015 08:21

e-Therapeutics Loss Widens As It Increases Development Spending

Read more
26 Feb 2015 14:12

e-Therapeutics Believes Drug Discovery Process Producing Higher Yield

Read more
23 Jan 2015 13:36

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Read more
21 Jan 2015 11:42

DIRECTOR DEALINGS: e-Therapeutics Finance Director Buys 150,000 Shares

Read more
16 Oct 2014 07:40

E-Therapeutics Appoints Sean Nicholson As Executive Director

Read more
16 Sep 2014 09:08

e-Therapeutics Loss Widens On Pipeline Development; Chair To Retire

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
4 Jul 2014 16:30

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or

Read more
4 Jul 2014 08:59

DIRECTOR DEALINGS: e-Therapeutics Finance Chief Buys 100,000 Shares

Read more
25 Jun 2014 16:02

DIRECTOR DEALINGS: e-Therapeutics Non-Executives Allotted New Shares

Read more
12 May 2014 11:49

e-Therapeutics Loss Widens As It Continues Pipeline Development

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e

Read more
8 May 2014 13:30

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians

Read more
8 May 2014 12:23

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.